September 2, 2019

CEO INTERVIEW: A sure sign of confidence for Norman Broadbent

Norman Broadbent (LON: NBB) CEO Michael Brennan joins DirectorsTalk to discuss how significant shareholders Judith MacKenzie of Downing Capital, Jon Moulton, and Pierce Casey increased stakes in the company. Michael..

Metal Tiger PLC Cobre investment & rapid progress being achieved at Perrinvale

Metal Tiger plc (LON:MTR), the London Stock Exchange AIM listed investor in strategic natural resource opportunities, has today announced that, following its announcements of 26 July 2019 and 27 August..

Dechra Pharmaceuticals continue to outperform

Dechra Pharmaceuticals plc (LON:CPH) has today announced its audited preliminary results for the year ended 30 June 2019. “The Group has delivered another strong performance throughout the financial year. We..

Alliance Trust PLC Portfolio Update: Appointment of Additional Manager

Alliance Trust PLC (LON: ATST) today announced that Willis Towers Watson, its appointed investment manager, has added Vulcan Value Partners (VVP) to its best-in-class1 multi-manager investment strategy, taking the number..

Woodford Patient Capital Trust plc Board Changes

The Board of Woodford Patient Capital Trust plc (LON: WPCT) announced today the appointment of Jane Tufnell as an independent non-executive director with immediate effect. Jane will also become a..

Centamin announce two new independent Non-Executive Directors

In accordance with the UK Corporate Governance Code, the Board has been steadily evolving as it establishes the optimal balance of core skills, experience and diversity. This is further supported..

AstraZeneca PLC Brilinta reduced the risk of cardiovascular events

Brilinta reduced the risk of cardiovascular events in patients with coronary artery disease and type-2 diabetes in Phase III THEMIS trial. Additionally, Brilinta showed a more favourable clinical benefit in..

AstraZeneca PLC “Farxiga so effective in trial”

AstraZeneca plc (LON:AZN) today announced detailed results from the landmark Phase III DAPA-HF trial that showed Farxiga on top of standard of care reduced both the incidence of cardiovascular death..

Micro Focus International Director declaration and resignation

Pursuant to Listing Rule 9.6.14(2) Micro Focus International (LON:MCRO) today announced that Kevin Loosemore, Executive Chairman, has been appointed to the Board of De La Rue plc as a non-executive..

Anglo Pacific Group PLC Acquisition of a producing copper royalty

Anglo Pacific Group PLC (LON: APF, TSX: APY) has today announced that it has entered into an agreement with a subsidiary of Mantos Copper, to acquire a 1.525% Net Smelter..

CentralNic Group PLC Revenues and Adjusted EBITDA triple Year-on-Year

CentralNic Group Plc (LON: CNIC), the global internet platform that derives revenue from the subscription sales of domain names and web services, is pleased to announcd today its half year..

Ilika Plc Annual Report, AGM and Directorate Change

Ilika plc (LON: IKA), a pioneer in solid-state battery technology, confirmed today that the Annual Report and Accounts for the year ended 30th April 2019 and the Notice of Annual..

Search

Funds

September 2, 2019

Search

Funds

September 2, 2019

FTSE 100

Funds